# Neuroprotective Effect of (Nano PSO), in Patients Who Used to Consume Psychoactive Substances

> **NCT06550167** · NA · RECRUITING · sponsor: **Distribuidora Biolife SA de CV** · enrollment: 80 (estimated)

## Conditions studied

- Addiction;Drug(S);LSD
- Neuroprotective

## Interventions

- **DIETARY_SUPPLEMENT:** Nano-PSO, Pomegranate seed oil (omega-5)
- **OTHER:** PLACEBO

## Key facts

- **NCT ID:** NCT06550167
- **Lead sponsor:** Distribuidora Biolife SA de CV
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-15
- **Primary completion:** 2026-03-30
- **Final completion:** 2027-03-15
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06550167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06550167, "Neuroprotective Effect of (Nano PSO), in Patients Who Used to Consume Psychoactive Substances". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06550167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*